Sort
64,565 grants matching “drug discovery”
Role of Host Protein Kinase C in Cryptosporidiosis
$701,643Chelsea S. Marie · University Of Virginia · R01 · FY2022 · AI
Epstein-Barr Virus LMP1-Mediated Oncogenecity
$701,405Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2015 · CA
Epstein-Barr Virus LMP1-Mediated Oncogenecity
$701,405Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2012 · CA
Micronized salsalate in a parenteral formulation is a safe and effective analgesic for acute postoperative pain management
$701,392Izhar Hasan · Rh Nanopharmacueticals L.L.C. · R44 · FY2022 · NS
Echogenic Targeted Liposomes: Transfection/Drug Delivery
$701,385David D McPherson · University Of Texas Hlth Sci Ctr Houston · R01 · FY2019 · HL
Frontotemporal Dementia Induced Pluripotent Stem Cell Consortium
$701,150Yadong Huang · J. David Gladstone Institutes · R01 · FY2014 · NS
Targeting cardiovascular events to improve patient outcomes after sepsis
$701,112Allan J. Walkey · Boston University Medical Campus · R01 · FY2019 · HL
HTS Assays for Modulators of GPCR Signaling
$701,073Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2010 · NS
Community Outreach and Engagement
$701,030Melissa A. Simon · Northwestern University At Chicago · P30 · FY2025 · CA
Tailoring Novel Therapeutics for Emerging Drug-Resistant C. Difficile Colitis
$700,893Richard L Guerrant · University Of Virginia · U01 · FY2008 · AI
X-Aptamer Selection Kit
$700,620Curtis Honming Lam · Am Biotechnologies, Llc · R44 · FY2015 · GM
Engineered Stem Cells for Cardiac Repair
$700,520Michael Regnier · University Of Washington · R01 · FY2018 · HL
HIGH-THROUGHPUT, HIGH-DIMENSIONAL (HT-HD) PHENOTYPING OF C. ELEGANS FOR ALS DRUG DISCOVERY
$700,494William Marsh Rice University · · FY2016 · Department of the Army
Pharmacogenetics and Cardiovascular Events
$700,395University Of Washington · R01 · FY2005 · HL
DDD Core
$700,360Gene D'amour · Xavier University Of Louisiana · G12 · FY2018 · MD
Identifying Organ-Specific Blood Biomarkers of Aging and Assessing their Effects on Cardiovascular Health
$700,310David Furman · Buck Institute For Research On Aging · U01 · FY2024 · AG
Targeting SARS-CoV-2 PLpro for COVID-19 treatment
$700,291Rui Xiong · University Of Arizona · R01 · FY2024 · AI
Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF
$700,288Naama Kanarek · Boston Children'S Hospital · R01 · FY2024 · CA
Mechanistic Study of Methotrexate-Induced Oxidative Distress in Neurons and the CSF
$700,288Naama Kanarek · Boston Children'S Hospital · R01 · FY2025 · CA
Multi-Center ALS Biomarker Validation Study (CReATe Biomarkers)
$700,180Michael Benatar · University Of Miami School Of Medicine · U01 · FY2021 · NS
Nanofiber Scaffolds for Salivary Gland Regeneration
$700,179Melinda Larsen · State University Of New York At Albany · R01 · FY2019 · DE
It's a tug of war: structure, consequences, and inhibition of CXCR4 and ACKR3 responses to lymphocyte chemoattractant CXCL12
$700,091Tracy M Handel · University Of California, San Diego · R01 · FY2021 · AI
Biomarkers for treatment monitoring and prognostication of disorders of hepatic copper metabolism
$700,053Michael L Schilsky · Yale University · R01 · FY2025 · DK
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$700,051Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$700,051Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA